Certain PARPi (e.g., olaparib) are known substrates for P-glycoprotein, which is an efflux transporter responsible for the resistance of cancers to numerous drugs, whereas other PARPi (e.g., veliparib) are not excreted [50]. Here, ABCB1 is linked to cancer.